Friday, April 25, 2025 | 11:19 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'

Icon Youtube
Business Standard

New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'

An anti-COVID oral drug developed by the DRDO has been approved by the Drugs Controller General of India (DCGI) for emergency use as an adjunct therapy in moderate to severe coronavirus patients. Clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Watch the video to know more.

Other Videos

Explore News